BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9673364)

  • 1. Treatment of thyroid carcinoma cells with four different suicide gene/prodrug combinations in vitro.
    Nishihara E; Nagayama Y; Narimatsu M; Namba H; Watanabe M; Niwa M; Yamashita S
    Anticancer Res; 1998; 18(3A):1521-5. PubMed ID: 9673364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
    Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y; Gilbert JD; Kim JH; Freytag SO
    Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
    Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
    Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma.
    Hoganson DK; Batra RK; Olsen JC; Boucher RC
    Cancer Res; 1996 Mar; 56(6):1315-23. PubMed ID: 8640820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of herpes simplex virus thymidine kinase and Escherichia coli nitroreductase by an hTERT-driven adenovirus vector in breast cancer cells results in additive anti-tumor effects.
    Yu B; Zhang Y; Zhan Y; Zha X; Wu Y; Zhang X; Dong Q; Kong W; Yu X
    Oncol Rep; 2011 Jul; 26(1):255-64. PubMed ID: 21573500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model.
    Moriuchi S; Wolfe D; Tamura M; Yoshimine T; Miura F; Cohen JB; Glorioso JC
    Gene Ther; 2002 May; 9(9):584-91. PubMed ID: 11973634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
    Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
    Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity.
    Rogulski KR; Kim JH; Kim SH; Freytag SO
    Hum Gene Ther; 1997 Jan; 8(1):73-85. PubMed ID: 8989997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current progress in suicide gene therapy for cancer.
    Yazawa K; Fisher WE; Brunicardi FC
    World J Surg; 2002 Jul; 26(7):783-9. PubMed ID: 11948367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.
    Kuriyama S; Mitoro A; Yamazaki M; Tsujinoue H; Nakatani T; Akahane T; Toyokawa Y; Kojima H; Okamoto S; Fukui H
    Scand J Gastroenterol; 1999 Oct; 34(10):1033-41. PubMed ID: 10563675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging.
    Sekar TV; Foygel K; Willmann JK; Paulmurugan R
    Gene Ther; 2013 May; 20(5):529-37. PubMed ID: 22914496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
    Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC
    Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor effects of cytosine deaminase and HSV-tk double suicide gene with adenovirus mediation on rectal cancer cells].
    Li S; Yu B; An P
    Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):577-9. PubMed ID: 11758189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of suicide gene systems in vascular cells in vitro.
    Xu LF; Xu DH; Ge K; Zheng ZC; Sun LY; Liu XY
    Cell Res; 1998 Mar; 8(1):73-8. PubMed ID: 9570019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The killing effects of two prodrug sensitivity genes on human pancreatic carcinoma cells PC-2].
    Zhang L; Liu T; Cui Q
    Zhonghua Bing Li Xue Za Zhi; 1998 Dec; 27(6):412-5. PubMed ID: 11244949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nitroreductase/CB1954 combination in Epstein-Barr virus-positive B-cell lines: induction of bystander killing in vitro and in vivo.
    Westphal EM; Ge J; Catchpole JR; Ford M; Kenney SC
    Cancer Gene Ther; 2000 Jan; 7(1):97-106. PubMed ID: 10678362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.
    Grignet-Debrus C; Cool V; Baudson N; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Nov; 7(11):1456-68. PubMed ID: 11129288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine.
    Lawrence TS; Rehemtulla A; Ng EY; Wilson M; Trosko JE; Stetson PL
    Cancer Res; 1998 Jun; 58(12):2588-93. PubMed ID: 9635583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.